LARGE-SCALE USE OF SABIN TYPE-2 ATTENUATED POLIOVIRUS VACCINE IN SINGAPORE DURING A TYPE-1 POLIOMYELITIS EPIDEMIC

被引：53

作者：

HALE, JH

DORAISINGHAM, M

KANAGARATNAM, K

LEONG, KW

MONTEIRO, ES

机构：

来源：

关键词：

D O I：

10.1136/bmj.1.5137.1541

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1541 / 1549

页数：9

共 14 条

[1] A SMALL-SCALE TRIAL OF TYPE-III ATTENUATED LIVING POLIOVIRUS VACCINE
CLARKE, SKR
GOFFE, AP
STUARTHARRIS, CH
HERZOG, EG
[J]. BRITISH MEDICAL JOURNAL, 1958, 2 (NOV15) : 1188 - 1193
[2] DICK GWA, 1957, BRIT MED J, V1, P70
[3] DICK GWA, 1957, BRIT MED J, V1, P65
[4] KOPROWSKI H, 1955, S Afr Med J, V29, P1134
[5] PAUL J R, 1958, Bull World Health Organ, V19, P747
[6] SABIN A, 1958, COMMUNICATION
[7] PRESENT POSITION OF IMMUNIZATION AGAINST POLIOMYELITIS WITH LIVE VIRUS VACCINES
SABIN, AB
[J]. BRITISH MEDICAL JOURNAL, 1959, 1 (MAR14) : 663 - 680
[8] PRESENT STATUS OF ATTENUATED LIVE-VIRUS POLIOMYELITIS VACCINE
SABIN, AB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 162 (18): : 1589 - 1596
[9] PROPERTIES AND BEHAVIOR OF ORALLY ADMINISTERED ATTENUATED POLIOVIRUS VACCINE
SABIN, AB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (11): : 1216 - 1223
[10] SABIN AB, 1957, NY ACAD SCI, V5, P113